WASHINGTON -- The Biden administration purchased an additional 200 million doses of Pfizer-BioNTech's COVID-19 vaccine to prepare for potential additional vaccine needs in the US, an administration ...
The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers. Pfizer, in particular, could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results